SlideShare a Scribd company logo
1 of 31
Dr. Muhammad Ayub, FCPS
     Diplomate Certification Board of Nuclear Cardiology
  Diplomate Board of Cardiovascular Computed Tomography

Assistant Professor of Cardiology
Myocardial Viability
Key questions
 What is Viable Myocardium?
 Why to Detect?
 What can it predict?
 How to Detect?
 Which technique is better?
Viable Myocardium
 Normal
 Reversible Ischaemia
 Partial Thickness Infarction
 Partial Thickness Infarction + Ischaemia
 Hibernating
 Stunning
Why to Detect?
• Ischemic LV dysfunction is common cause of cardiac failure
  resulting in bad prognosis.

• Patients with ischemic LV dysfunction and viable myocardium
  often improve after revascularization.

• Numerous studies have suggested that identification of
  viable myocardium also predicts improved survival following
  revascularization
What it can predict?
Viability and Prognosis
Based on 20 Studies (n=2362)




         Viable Myocardium     Scarred Myocardium
Myocardial Viability and Cardiovascular Mortality
                                         1.0
                                                           Without viability
                                                           With viability
                                                                                       Univariate               Multivariable
                                         0.8
         Cardiovascular Mortality Rate

                                                     HR    95% CI    P            Chi-square p value         Chi-square    p value
                                                     0.61 0.44,0.84 0.003
                                                                                      8.81         0.003        0.91       0.339
                                         0.6


                                         0.4


                                         0.2



                                         0.0
                                               0            1             2           3         4                5           6
                                                                          Years from Randomization
Without viability 114                                    99          85         80            63        36            16
With viability    487                                    432        409         371          294       188           102
How to Detect viable Myocardium?
Physiological Basis
   Contractile Reserve
   Preserved Cellular Metabolism
   Cell Membrane Integrity
Contractile Reserve
   Dobutamine Stress Echocardiography
   Gated Myocardial Perfusion SPECT
   Dobutamine MRI
Dobutamine Echocardiography
Biphasic response to Dobutamine
Stress Echocardiography

Studies= 19 (n=448)
            Sensitivity: 84%
           Specificity: 81%
Contractile Reserve with Gated SPECT for
 Myocardial Viability

Both perfusion and wall
motion detection.
 LV EF and ventricular
volumes calculation.
 3-D display of endocardial,
epicardial or of both.
 Regional quantitation by its
polar map system.
GSPECT with Low Dose Dobutamine
 Baseline GSPECT study
 Low dose dobutamine SPECT study
    Areas with contractile reserve – Viable
    Areas without contractile reserve -- Scar
Preserved Cell Metabolism
  Glucose            F-18 FDG
  Free Fatty Acids   I-123 BMIPP
                     C-11 Palmitate
                     C-11 Acetate
PET Perfusion and Metabolism

 Perfusion




Metabolism
PET Perfusion /Metabolism Mismatch




                  Ghosh N et al. Eur Heart J 2010;eurheartj.ehq361
PET Perfusion /Metabolism Match




 Ghosh N et al. Eur Heart J 2010
F-18 FDG PET


Studies= 11 (n=332)

        Sensitivity:    88%
        Specificity:    73%
Cell Membrane Integrity

 Imaging of choice, where PET is not available.

 Thallium (Tl -201 ) or Tc-99m MIBI are commonly
 radioisotopes used for this purpose.

 Cellular uptake of Tl-201 and Tc-99m Sestamibi is
 dependant on intact cell membrane.
Protocol of Tl-201 for HM

Stress,   redistribution, and 24 hours delayed imaging.

Stress,   redistribution, and reinjection imaging.

Stress,   immediate reinjection, and redistribution imaging.

Rest   and redistribution imaging.
Rest Redistribution Tl-201 SPECT
Rest Redistribution Tl-201 SPECT
         Scar Myocardium
Tc-99m MIBI
 Second most commonly used perfusion agent.
 It enters passively through the cell membrane.
 Concentration in cytosol is 5:1, whereas it increases
  up to 300:1 in mitochondria.
 Tc-99m Sestamibi does not redistribute after initial
  uptake
 Administration of nitrates prior to Sestamibi
  injection improves uptake in viable areas
Nitrates and Viability
Other Agents

  Trimetazidine
  Tricardin




                   Improvement with administration of nitrates as well as trimetazidine
Comparison of various techniques for the prediction of
recovery of regional function after revascularization.




                                          Ghosh N et al. Eur Heart J 2010
Cardiac MRI for myocardial viability
 One of the non-invasive technique for viability.
 High spatial and temporal resolution
 Significant concordance between Gated MRI and
 post-revascularization findings.
MR Assessment of Myocardial Viability

            N Myocardium
   Gd
injection
                               infarct




                1st pass     Delayed     time
                           enhancement
MDCT for Myocardial Viability
Final word
 All available techniques have good sensitivity and
 specificity for detection of myocardial viability.

 Techniques using contractile reserve are more specific
 but nuclear techniques are sensitive for assessment of
 myocardial viability.
Unresolved Issues In Myocardial Viability

More Related Content

What's hot

Coronary artery dissection and perforation
Coronary artery dissection and perforationCoronary artery dissection and perforation
Coronary artery dissection and perforationFuad Farooq
 
Left main coronary artery disease
Left main coronary artery diseaseLeft main coronary artery disease
Left main coronary artery diseaseRamachandra Barik
 
Ischemic ventricular septal_defects_dr.asma
Ischemic ventricular septal_defects_dr.asmaIschemic ventricular septal_defects_dr.asma
Ischemic ventricular septal_defects_dr.asmaESmi AwAn
 
Appropriate use criteria for intervetion in ACS , JACC
Appropriate use criteria for intervetion in ACS , JACCAppropriate use criteria for intervetion in ACS , JACC
Appropriate use criteria for intervetion in ACS , JACCTammiraju Iragavarapu
 
The hibernating myocardium
The hibernating myocardiumThe hibernating myocardium
The hibernating myocardiummadhusiva03
 
Double kissing crush v trial
Double kissing crush v trialDouble kissing crush v trial
Double kissing crush v trialAhmed Kamel
 
No reflow phenomenon by dr. deepchandh
No reflow phenomenon by dr. deepchandhNo reflow phenomenon by dr. deepchandh
No reflow phenomenon by dr. deepchandhDeep Chandh
 
No reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pciNo reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pcirahul arora
 
CRT Non Responders - A practical guide
CRT Non Responders - A practical guideCRT Non Responders - A practical guide
CRT Non Responders - A practical guideRaghu Kishore Galla
 
Assessment of myocardial viability
Assessment of myocardial viabilityAssessment of myocardial viability
Assessment of myocardial viabilityAshish Golwara
 
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...hospital
 
Percutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MRPercutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MRYogesh Shilimkar
 
Cardiac resynchronization
Cardiac resynchronizationCardiac resynchronization
Cardiac resynchronizationmariebma
 

What's hot (20)

Coronary artery dissection and perforation
Coronary artery dissection and perforationCoronary artery dissection and perforation
Coronary artery dissection and perforation
 
Left main coronary artery disease
Left main coronary artery diseaseLeft main coronary artery disease
Left main coronary artery disease
 
Ischemic ventricular septal_defects_dr.asma
Ischemic ventricular septal_defects_dr.asmaIschemic ventricular septal_defects_dr.asma
Ischemic ventricular septal_defects_dr.asma
 
Appropriate use criteria for intervetion in ACS , JACC
Appropriate use criteria for intervetion in ACS , JACCAppropriate use criteria for intervetion in ACS , JACC
Appropriate use criteria for intervetion in ACS , JACC
 
Bifurcation stenting
Bifurcation stentingBifurcation stenting
Bifurcation stenting
 
Role of CRT and CRTD in CHF
Role of CRT and CRTD in CHFRole of CRT and CRTD in CHF
Role of CRT and CRTD in CHF
 
The hibernating myocardium
The hibernating myocardiumThe hibernating myocardium
The hibernating myocardium
 
Double kissing crush v trial
Double kissing crush v trialDouble kissing crush v trial
Double kissing crush v trial
 
Management of no reflow
Management of no reflowManagement of no reflow
Management of no reflow
 
Left main stenting
Left main stentingLeft main stenting
Left main stenting
 
Myocardial viability
Myocardial viabilityMyocardial viability
Myocardial viability
 
No reflow phenomenon by dr. deepchandh
No reflow phenomenon by dr. deepchandhNo reflow phenomenon by dr. deepchandh
No reflow phenomenon by dr. deepchandh
 
Trans septal puncture
Trans septal punctureTrans septal puncture
Trans septal puncture
 
No reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pciNo reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pci
 
CRT Non Responders - A practical guide
CRT Non Responders - A practical guideCRT Non Responders - A practical guide
CRT Non Responders - A practical guide
 
Assessment of myocardial viability
Assessment of myocardial viabilityAssessment of myocardial viability
Assessment of myocardial viability
 
PBMV:Tips and Tricks
PBMV:Tips and TricksPBMV:Tips and Tricks
PBMV:Tips and Tricks
 
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
 
Percutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MRPercutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MR
 
Cardiac resynchronization
Cardiac resynchronizationCardiac resynchronization
Cardiac resynchronization
 

Viewers also liked

Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011callroom
 
Pharmacological stress echocardiography
Pharmacological stress echocardiographyPharmacological stress echocardiography
Pharmacological stress echocardiographySatyam Rajvanshi
 
Stitch trial
Stitch trialStitch trial
Stitch trialauriom
 
Ischaemic cardiomyopathy revascularisation how when and why
Ischaemic cardiomyopathy  revascularisation how when and whyIschaemic cardiomyopathy  revascularisation how when and why
Ischaemic cardiomyopathy revascularisation how when and whycardiositeindia
 
Myocardial perfusion imaging SPECT basics
Myocardial perfusion imaging SPECT basicsMyocardial perfusion imaging SPECT basics
Myocardial perfusion imaging SPECT basicsJennifer Gutiérrez
 

Viewers also liked (8)

Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011Myocardial Viability - the STICH Trial NEJM May 2011
Myocardial Viability - the STICH Trial NEJM May 2011
 
Dobutamine stress echo in myocardial viability assessment
Dobutamine stress echo in myocardial viability assessmentDobutamine stress echo in myocardial viability assessment
Dobutamine stress echo in myocardial viability assessment
 
Pharmacological stress echocardiography
Pharmacological stress echocardiographyPharmacological stress echocardiography
Pharmacological stress echocardiography
 
Stitch trial
Stitch trialStitch trial
Stitch trial
 
Ischaemic cardiomyopathy revascularisation how when and why
Ischaemic cardiomyopathy  revascularisation how when and whyIschaemic cardiomyopathy  revascularisation how when and why
Ischaemic cardiomyopathy revascularisation how when and why
 
Dobutamine stress echo
Dobutamine stress echoDobutamine stress echo
Dobutamine stress echo
 
LV Dyssynchrony assessment
LV Dyssynchrony assessmentLV Dyssynchrony assessment
LV Dyssynchrony assessment
 
Myocardial perfusion imaging SPECT basics
Myocardial perfusion imaging SPECT basicsMyocardial perfusion imaging SPECT basics
Myocardial perfusion imaging SPECT basics
 

Similar to Unresolved Issues In Myocardial Viability

IGRT & IMRT In Head Neck Cancer
IGRT & IMRT In Head Neck CancerIGRT & IMRT In Head Neck Cancer
IGRT & IMRT In Head Neck CancerSapna Nangia
 
State of the art mitral valve repair
State of the art mitral valve repairState of the art mitral valve repair
State of the art mitral valve repairdrmaisano
 
Surgical management of adrenal mets third part
Surgical management of adrenal mets third partSurgical management of adrenal mets third part
Surgical management of adrenal mets third partJJSancho
 
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenLarynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenEurasian Federation of Oncology
 
Myocardial Viability Biplave.pptx
Myocardial Viability Biplave.pptxMyocardial Viability Biplave.pptx
Myocardial Viability Biplave.pptxbiplave karki
 
Tu Esmo Imaging Of Glioma Ppt
Tu Esmo Imaging Of Glioma PptTu Esmo Imaging Of Glioma Ppt
Tu Esmo Imaging Of Glioma Pptfondas vakalis
 
Igrt In Gynecologic Malignancies
Igrt In Gynecologic MalignanciesIgrt In Gynecologic Malignancies
Igrt In Gynecologic Malignanciesfondas vakalis
 
Igrt For Prostate Cancer
Igrt For Prostate CancerIgrt For Prostate Cancer
Igrt For Prostate CancerSapna Nangia
 
Elective Nodal Irradiation #radonc
Elective Nodal Irradiation #radoncElective Nodal Irradiation #radonc
Elective Nodal Irradiation #radoncRichard Simcock
 
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suhDr. Vijay Anand P. Reddy
 
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)European School of Oncology
 
ROSE CASE CARDIAC ARRHYTHMIA SBRT
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRTKanhu Charan
 
Cardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copyCardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copyhospital
 
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...Centro Diagnostico Nardi
 
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryOleg Kshivets
 

Similar to Unresolved Issues In Myocardial Viability (20)

Current Modalities in the Treatment of Lung Cancer
Current Modalities in the Treatment of Lung CancerCurrent Modalities in the Treatment of Lung Cancer
Current Modalities in the Treatment of Lung Cancer
 
IGRT & IMRT In Head Neck Cancer
IGRT & IMRT In Head Neck CancerIGRT & IMRT In Head Neck Cancer
IGRT & IMRT In Head Neck Cancer
 
State of the art mitral valve repair
State of the art mitral valve repairState of the art mitral valve repair
State of the art mitral valve repair
 
Surgical management of adrenal mets third part
Surgical management of adrenal mets third partSurgical management of adrenal mets third part
Surgical management of adrenal mets third part
 
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenLarynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
 
5
55
5
 
Myocardial Viability Biplave.pptx
Myocardial Viability Biplave.pptxMyocardial Viability Biplave.pptx
Myocardial Viability Biplave.pptx
 
Tu Esmo Imaging Of Glioma Ppt
Tu Esmo Imaging Of Glioma PptTu Esmo Imaging Of Glioma Ppt
Tu Esmo Imaging Of Glioma Ppt
 
MON 2011 - Slide 22 - W. Weder - Surgery
MON 2011 - Slide 22 - W. Weder - SurgeryMON 2011 - Slide 22 - W. Weder - Surgery
MON 2011 - Slide 22 - W. Weder - Surgery
 
Igrt In Gynecologic Malignancies
Igrt In Gynecologic MalignanciesIgrt In Gynecologic Malignancies
Igrt In Gynecologic Malignancies
 
Cardiac MRI
Cardiac MRICardiac MRI
Cardiac MRI
 
Igrt For Prostate Cancer
Igrt For Prostate CancerIgrt For Prostate Cancer
Igrt For Prostate Cancer
 
Elective Nodal Irradiation #radonc
Elective Nodal Irradiation #radoncElective Nodal Irradiation #radonc
Elective Nodal Irradiation #radonc
 
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
 
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
H. Van Poppel - Kidney cancer - Surgery (including nephron-sparing surgery)
 
ROSE CASE CARDIAC ARRHYTHMIA SBRT
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRT
 
Cardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copyCardio respiratory nuclear imaging ihab - copy
Cardio respiratory nuclear imaging ihab - copy
 
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
 
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
 
Definition of vulnerable plaque naghavi- thi
Definition of vulnerable plaque  naghavi- thiDefinition of vulnerable plaque  naghavi- thi
Definition of vulnerable plaque naghavi- thi
 

More from Muhammad Ayub

Heart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of ImageryHeart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of ImageryMuhammad Ayub
 
Diagnosis of Cardiac Amyloidosis with PYP Imaging
Diagnosis of Cardiac Amyloidosis with PYP ImagingDiagnosis of Cardiac Amyloidosis with PYP Imaging
Diagnosis of Cardiac Amyloidosis with PYP ImagingMuhammad Ayub
 
Cardiac mdct for determining aetiology of pulmonary hypertension
Cardiac mdct for determining aetiology of  pulmonary hypertensionCardiac mdct for determining aetiology of  pulmonary hypertension
Cardiac mdct for determining aetiology of pulmonary hypertensionMuhammad Ayub
 
MDCT for Congenital Heart Disease
MDCT for Congenital Heart DiseaseMDCT for Congenital Heart Disease
MDCT for Congenital Heart DiseaseMuhammad Ayub
 
Clinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac CtClinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac CtMuhammad Ayub
 
Digital Techniques For Myocardial Perfusion Spect
Digital Techniques For Myocardial Perfusion SpectDigital Techniques For Myocardial Perfusion Spect
Digital Techniques For Myocardial Perfusion SpectMuhammad Ayub
 
Nuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology CmeNuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology CmeMuhammad Ayub
 
Cardiovascular Imaging
Cardiovascular ImagingCardiovascular Imaging
Cardiovascular ImagingMuhammad Ayub
 

More from Muhammad Ayub (8)

Heart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of ImageryHeart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of Imagery
 
Diagnosis of Cardiac Amyloidosis with PYP Imaging
Diagnosis of Cardiac Amyloidosis with PYP ImagingDiagnosis of Cardiac Amyloidosis with PYP Imaging
Diagnosis of Cardiac Amyloidosis with PYP Imaging
 
Cardiac mdct for determining aetiology of pulmonary hypertension
Cardiac mdct for determining aetiology of  pulmonary hypertensionCardiac mdct for determining aetiology of  pulmonary hypertension
Cardiac mdct for determining aetiology of pulmonary hypertension
 
MDCT for Congenital Heart Disease
MDCT for Congenital Heart DiseaseMDCT for Congenital Heart Disease
MDCT for Congenital Heart Disease
 
Clinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac CtClinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac Ct
 
Digital Techniques For Myocardial Perfusion Spect
Digital Techniques For Myocardial Perfusion SpectDigital Techniques For Myocardial Perfusion Spect
Digital Techniques For Myocardial Perfusion Spect
 
Nuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology CmeNuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology Cme
 
Cardiovascular Imaging
Cardiovascular ImagingCardiovascular Imaging
Cardiovascular Imaging
 

Unresolved Issues In Myocardial Viability

  • 1. Dr. Muhammad Ayub, FCPS Diplomate Certification Board of Nuclear Cardiology Diplomate Board of Cardiovascular Computed Tomography Assistant Professor of Cardiology
  • 2. Myocardial Viability Key questions  What is Viable Myocardium?  Why to Detect?  What can it predict?  How to Detect?  Which technique is better?
  • 3. Viable Myocardium  Normal  Reversible Ischaemia  Partial Thickness Infarction  Partial Thickness Infarction + Ischaemia  Hibernating  Stunning
  • 4. Why to Detect? • Ischemic LV dysfunction is common cause of cardiac failure resulting in bad prognosis. • Patients with ischemic LV dysfunction and viable myocardium often improve after revascularization. • Numerous studies have suggested that identification of viable myocardium also predicts improved survival following revascularization
  • 5. What it can predict? Viability and Prognosis Based on 20 Studies (n=2362) Viable Myocardium Scarred Myocardium
  • 6. Myocardial Viability and Cardiovascular Mortality 1.0 Without viability With viability Univariate Multivariable 0.8 Cardiovascular Mortality Rate HR 95% CI P Chi-square p value Chi-square p value 0.61 0.44,0.84 0.003 8.81 0.003 0.91 0.339 0.6 0.4 0.2 0.0 0 1 2 3 4 5 6 Years from Randomization Without viability 114 99 85 80 63 36 16 With viability 487 432 409 371 294 188 102
  • 7. How to Detect viable Myocardium? Physiological Basis Contractile Reserve Preserved Cellular Metabolism Cell Membrane Integrity
  • 8. Contractile Reserve Dobutamine Stress Echocardiography Gated Myocardial Perfusion SPECT Dobutamine MRI
  • 10. Biphasic response to Dobutamine
  • 11. Stress Echocardiography Studies= 19 (n=448) Sensitivity: 84% Specificity: 81%
  • 12. Contractile Reserve with Gated SPECT for Myocardial Viability Both perfusion and wall motion detection. LV EF and ventricular volumes calculation. 3-D display of endocardial, epicardial or of both. Regional quantitation by its polar map system.
  • 13. GSPECT with Low Dose Dobutamine  Baseline GSPECT study  Low dose dobutamine SPECT study  Areas with contractile reserve – Viable  Areas without contractile reserve -- Scar
  • 14. Preserved Cell Metabolism Glucose F-18 FDG Free Fatty Acids I-123 BMIPP C-11 Palmitate C-11 Acetate
  • 15. PET Perfusion and Metabolism Perfusion Metabolism
  • 16. PET Perfusion /Metabolism Mismatch Ghosh N et al. Eur Heart J 2010;eurheartj.ehq361
  • 17. PET Perfusion /Metabolism Match Ghosh N et al. Eur Heart J 2010
  • 18. F-18 FDG PET Studies= 11 (n=332) Sensitivity: 88% Specificity: 73%
  • 19. Cell Membrane Integrity  Imaging of choice, where PET is not available.  Thallium (Tl -201 ) or Tc-99m MIBI are commonly radioisotopes used for this purpose.  Cellular uptake of Tl-201 and Tc-99m Sestamibi is dependant on intact cell membrane.
  • 20. Protocol of Tl-201 for HM Stress, redistribution, and 24 hours delayed imaging. Stress, redistribution, and reinjection imaging. Stress, immediate reinjection, and redistribution imaging. Rest and redistribution imaging.
  • 22. Rest Redistribution Tl-201 SPECT Scar Myocardium
  • 23. Tc-99m MIBI  Second most commonly used perfusion agent.  It enters passively through the cell membrane.  Concentration in cytosol is 5:1, whereas it increases up to 300:1 in mitochondria.  Tc-99m Sestamibi does not redistribute after initial uptake  Administration of nitrates prior to Sestamibi injection improves uptake in viable areas
  • 25. Other Agents  Trimetazidine  Tricardin Improvement with administration of nitrates as well as trimetazidine
  • 26. Comparison of various techniques for the prediction of recovery of regional function after revascularization. Ghosh N et al. Eur Heart J 2010
  • 27. Cardiac MRI for myocardial viability  One of the non-invasive technique for viability.  High spatial and temporal resolution  Significant concordance between Gated MRI and post-revascularization findings.
  • 28. MR Assessment of Myocardial Viability N Myocardium Gd injection infarct 1st pass Delayed time enhancement
  • 29. MDCT for Myocardial Viability
  • 30. Final word  All available techniques have good sensitivity and specificity for detection of myocardial viability.  Techniques using contractile reserve are more specific but nuclear techniques are sensitive for assessment of myocardial viability.